about
A statistical approach to central monitoring of data quality in clinical trials.Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.Adjuvant trastuzumab in HER2-positive breast cancer.Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
P50
description
onderzoeker
@nl
name
Valerie Bee
@ast
Valerie Bee
@en
Valerie Bee
@es
Valerie Bee
@sl
type
label
Valerie Bee
@ast
Valerie Bee
@en
Valerie Bee
@es
Valerie Bee
@sl
prefLabel
Valerie Bee
@ast
Valerie Bee
@en
Valerie Bee
@es
Valerie Bee
@sl